7 Clinics · Kerala & Tamil Nadu · +91 80860 00608 · help@dermavue.com
Overview GLP-1 Injections Belly Fat Ozempic & Wegovy Mounjaro Generic GLP-1 Am I Eligible? PCOS Quiz Titration Tool Diet Plan Exercise Plan
Medical weight loss program at DermaVue clinics in Kerala and Tamil Nadu
DermaVue SuperHuman Medical Weight Loss Program
DermaVue SuperHuman Program Physician-Led GLP-1

Medical Weight Loss in India: Lose Belly Fat, Keep Your Muscle.

India's Leading Physician-Led GLP-1 Weight Loss Program. Doctor-supervised GLP-1 injections with Ozempic, Mounjaro & Wegovy across Kerala & Tamil Nadu.

RM
Dr. Rejeesh Menon, MD Medical Director, DermaVue Clinics
From ₹325/wkGeneric semaglutide
7 ClinicsKerala & Tamil Nadu
4.8 / 57,200+ Reviews
20%+Weight Loss
Take the Free Eligibility Test
Quick Answer

Medical weight loss in India is doctor-supervised therapy that combines GLP-1 injections like Ozempic (Novo Nordisk), Wegovy (Novo Nordisk), and Mounjaro (Eli Lilly) with nutrition coaching, resistance training, and metabolic monitoring. DermaVue Clinics runs the SuperHuman Program at 7 physician-led centres across Kerala and Tamil Nadu, generic semaglutide from ₹325/week, Ozempic from ₹1,415/week, Mounjaro from ₹3,281/week.

Clinical Summary

The DermaVue Clinics medical team developed the SuperHuman Program around the South Asian thin-fat phenotype, where visceral fat is high even at normal BMI. The protocol combines doctor-prescribed GLP-1 therapy with a 1.2 to 1.6 g/kg protein target, structured resistance training, and monthly metabolic review. Treatment is delivered across 7 physician-led DermaVue centres in Kerala and Tamil Nadu, with over 7,200 patient reviews and a 4.8 average star rating. The program focuses on muscle preservation and visceral fat loss, not scale weight alone.

IADVL Registered
US-FDA Approved
Board-Certified Physicians
10+ Years Experience
Board-Certified Medical Weight Loss

DermaVue SuperHuman is a physician-supervised medical weight loss program operating across seven board-certified dermatology clinics in Kerala and Tamil Nadu, India. The program uses US-FDA approved GLP-1 receptor agonists including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro), combined with clinical dietitian support, body composition monitoring, and a proprietary Face-Saver dermatology protocol. Founded by Dr. Rejeesh Menon MD and Dr. Sarath Chandran MD DVL, DermaVue maintains a 4.8-star rating from over 7,200 patient reviews. Generic semaglutide starts from ₹325 per weekly injection, Ozempic (Novo Nordisk) from ₹1,415 per weekly injection, Mounjaro (Eli Lilly) from ₹3,281 per weekly injection. Locations: Thiruvananthapuram, Kollam, Thiruvalla, Kottayam, Kochi, Thrissur, and Coimbatore.

The Science

Why Indians Gain Weight Differently

Indian phenotype visceral fat comparison showing thin-fat Indian body composition

The “Thin-Fat Indian” Problem

Research shows one-third of Indians with “normal” weight carry dangerous levels of hidden visceral fat. At the same BMI, Indians have significantly higher body fat percentage than Europeans. Placing them at elevated risk for diabetes, heart disease, and metabolic syndrome.

21.2%
Indian body fat (BMI 22.3)
9.1%
European body fat (BMI 22.3)

Same BMI. Completely different health risk.

Source: Yajnik CS, The Lancet, 2004. “The thin-fat Indian baby: differences in body composition and metabolic risk.”

Know Your Numbers

The New Indian BMI Standards

Indian-specific BMI cutoffs are lower than international standards. Because Indians develop metabolic complications at lower body weight.

Category Indian Cutoff International (WHO)
NormalBelow 23Below 25
Overweight23-24.925-29.9
Obese25 and above30 and above

Important: Even if your BMI is normal, you may still be at high metabolic risk. BMI alone does not reveal visceral fat, insulin resistance, or metabolic syndrome. A clinical assessment is essential.

Take the Free GLP-1 Eligibility Test Or Book a Consultation

3 minutes. Physician-designed. Your data stays private.

The Program

The SuperHuman 3-Pillar Program

Not a diet. Not a gym plan. A medically supervised system that addresses the root causes of weight gain in the Indian body.

Pillar 1

Pillar 1: Medical (GLP-1 Therapy)

Physician-prescribed GLP-1 receptor agonist injections (Mounjaro or Ozempic) with structured dose titration, monthly medical review, and body composition tracking. Targets visceral belly fat at the hormonal level.

Pillar 2

Pillar 2: Nutrition (Clinical Dietitian)

45 to 60 minute initial dietitian assessment followed by weekly check-ins. Protein optimization at 1.2 to 1.6 g/kg ideal body weight, Indian meal planning, and macro tracking to preserve lean muscle during fat loss.

Pillar 3

Pillar 3: Movement (Exercise Guidance)

Structured resistance training protocol designed to prevent the muscle loss that affects up to 45% of unsupervised GLP-1 weight loss. Creatine supplementation guidance and progressive overload tracking.

The Mechanism

How GLP-1 Works in the Indian Body

GLP-1 receptor agonists work through multiple biological pathways to address the specific metabolic challenges faced by Indian patients.

Appetite Regulation

GLP-1 acts on the hypothalamus to reduce hunger signals, making it easier to maintain a caloric deficit without the constant willpower battle. Patients report feeling satisfied with smaller portions within the first 2 weeks.

Visceral Fat Targeting

Unlike dieting alone, GLP-1 medications preferentially reduce visceral (belly) fat. The metabolically dangerous fat that wraps around organs and drives insulin resistance in the Indian thin-fat phenotype.

Insulin Sensitivity

GLP-1 improves pancreatic beta-cell function and enhances insulin sensitivity, directly addressing the insulin resistance that is disproportionately common in South Asian populations even at lower BMI levels.

Gastric Slowing

By slowing gastric emptying, GLP-1 extends the feeling of fullness after meals, reduces post-meal blood sugar spikes, and helps patients naturally eat less. Particularly effective with traditional Indian carb-heavy meals.

Dermatologist-supervised GLP-1 weight loss program at DermaVue preventing Ozempic face
DermaVue's dermatology advantage. Skin protection built into every weight loss program
Treatment Options

Which Medication Is Right for You?

Your physician will recommend the optimal GLP-1 medication based on your metabolic profile, health history, and treatment goals.

First-Line Recommendation

Tirzepatide (Mounjaro)

  • ✓ Dual GIP + GLP-1 receptor agonist
  • ✓ Up to 22.5% weight loss (SURMOUNT-1 trial)
  • ✓ Superior for visceral fat reduction in Indian patients
  • ✓ Weekly injection. Physician-administered or self-injection
Learn About Mounjaro

Semaglutide (Ozempic / Wegovy)

  • ✓ Single GLP-1 receptor agonist
  • ✓ Up to 14.9% weight loss (STEP 1 trial)
  • ✓ Proven safety profile since 2017
  • ✓ Also available as oral tablet (Rybelsus) for maintenance
Learn About Ozempic & Wegovy
Transparent Pricing · India · April 2026

Generic semaglutide from ₹325 / week

Novo Nordisk's Indian semaglutide patent expired on 20 March 2026. Forty-plus DCGI-approved generic brands now ship across Kerala and Tamil Nadu. Below is the starting price for each medication category, clearly differentiated, no ranges, no package tiers.

Medication Starts from
Generic semaglutide , vial Natco Semanat · drawn with insulin syringe ₹325 / week
Generic semaglutide , pre-filled pen Alkem Semasize · Dr. Reddy's Obeda · Zydus Semaglyn ₹450 / week
Ozempic (Novo Nordisk) Branded semaglutide pen · 4-week pack ₹5,660 ÷ 4 = ₹1,415/wk ₹1,415 / week
Mounjaro (Eli Lilly) Branded tirzepatide · dual GIP / GLP-1 · Cipla Yurpeak ₹3,281 / week

Pen-format generics are sold as a sealed 4-week device; per-week figures are pen MRP divided by four. The full brand-by-brand breakdown is in our Generic Semaglutide India 2026 guide.

Compare All 8 Generic Brands Book Your Consultation
Your Protocol

What Happens After You Book?

From first inquiry to visible results, here is your step-by-step path through the SuperHuman Program.

1

WhatsApp / Online Inquiry

Reach out via WhatsApp or our booking form. Our coordinator will collect basic health details and schedule your first consultation.

2

Dietitian Consultation (45 to 60 min)

A full nutrition and lifestyle assessment covering diet history, eating patterns, activity level, and metabolic risk screening.

3

Mandatory Lab Panel

HbA1c, Fasting Insulin, HOMA-IR, Complete Lipids, TSH, LFT, eGFR, Vitamin D3, and B12. Lab form sent after the dietitian consultation.

4

Dermatologist Medical Clearance

Your dermatologist reviews labs, assesses skin health baseline, and confirms GLP-1 eligibility with a personalized dosing plan.

5

GLP-1 Therapy Initiation + Monthly Monitoring

Start Mounjaro (Tirzepatide) or Ozempic (Semaglutide) at the lowest effective dose with structured titration under medical supervision. Monthly body composition tracking ensures you lose fat, not muscle.

Book Your SuperHuman Consultation

Generic GLP-1 Update. March 2026

Generic semaglutide entered the Indian market in March 2026. Branded Ozempic at 0.5 mg weekly previously ran around Rs 8,100 per month. Indian generics from Natco, Alkem, and Dr. Reddy's now sit between Rs 1,290 and Rs 4,200 at the same dose. The molecule and safety profile are identical. Physician supervision is still required because GLP-1 therapy carries real contraindications. Cheaper does not mean safer to self-prescribe.

Read the full generic GLP-1 India guide →

Related Resources

Continue Reading

GLP-1 Injections

How GLP-1 therapy targets belly fat in Indian patients.

Am I Eligible for GLP-1?

Free 3-minute physician-designed eligibility test for GLP-1.

Generic Semaglutide India 2026

Brand-by-brand pricing guide to Indian GLP-1 generics.
Complete Resource Library

Every SuperHuman Tool, Protocol and Guide

A physician-built resource map covering medications, interactive tools, protocols, and Indian lifestyle plans across the DermaVue SuperHuman programme.

Medications and Comparisons

Visceral Fat and Thin-Fat Phenotype Guide

How belly fat reduction works in the South Asian thin-fat phenotype, with imaging and metabolic markers.

Fat Burner vs GLP-1 Comparison

A side-by-side clinical comparison of OTC fat burners and physician-prescribed GLP-1 therapy.

18-Trial GLP-1 Clinical Evidence Library

STEP, SURMOUNT, SELECT, FLOW and the full set of trials behind every DermaVue SuperHuman protocol.

Interactive Tools

PCOS Insulin Resistance Risk Assessment

A 2-minute physician-built quiz to check insulin resistance risk in Indian women with PCOS.

GLP-1 Dose Titration Protocol Tool

The safe semaglutide and tirzepatide dose escalation schedule used in DermaVue clinics.

Calorie Deficit Calculator for Indians

BMR, TDEE and a safe daily calorie target tuned to Indian body composition.

Protocols and Lifestyle

Physician Food List for Indians

The full DermaVue weight loss food list with kcal, protein and glycaemic load from ICMR-NIN data.

7-Day Kerala Meal Plan

A ready-to-follow 7-day Indian meal template with non-veg and vegetarian variants.

Weight Loss for Women in India

Hormone-aware metabolic care for PCOS, post-partum and menopause weight gain.

PCOS and GLP-1 Deep Dive

How semaglutide and tirzepatide treat PCOS-driven insulin resistance and hyperandrogenism.

GLP-1 Side Effect Management Protocol

Step-by-step physician protocol for nausea, reflux and constipation on GLP-1 therapy.

Complete GLP-1 Side Effects Guide

Common, serious and rare side effects of semaglutide and tirzepatide with red-flag triage.

Cities and Service Areas

DermaVue's GLP-1 program is delivered through seven Kerala district pages, each calibrated to local epidemiology, cold-chain logistics, and cultural diet. Pricing across all districts holds at generic semaglutide from ₹325 per week, Ozempic (Novo Nordisk) from ₹1,415, Mounjaro (Eli Lilly) from ₹3,281. Pick your district below.

Medical Weight Loss in Alappuzha

Backwater rice-belt district where the SLICK and ICMR-INDIAB cohorts established Kerala's diabetes prevalence baseline. GLP-1 program runs from DermaVue Thiruvalla with monthly cold-chain dispatch to Cherthala and Kuttanad.

Medical Weight Loss in Kannur

Indian Naval Academy and handloom-weaver occupational profiles drive a split protocol for trained athletes versus seated weavers. Oldest median age in North Kerala, screened for sarcopenic obesity.

Medical Weight Loss in Kasaragod

Kerala's lowest specialist-physician density combined with cross-border Mangalore healthcare flow. Tool output is multilingual across Malayalam, Kannada, Tulu and Beary; areca-nut intake is documented at intake per IARC Group 1 status.

Medical Weight Loss in Kozhikode

Medical-hub district with two cohorts on a single titration ladder: Gulf-returnee patients arriving with established diabetes panels, plus an IT corridor sedentary phenotype. Cold-chain courier from DermaVue Calicut.

Medical Weight Loss in Malappuram

Youngest median age in Kerala and the only district running a fasted-state Ramadan GLP-1 timing protocol. Puzhakkatiri's 30 percent diabetes outlier is screened at intake.

Medical Weight Loss in Palakkad

Rice-belt district with the Palghat Iyer high-carbohydrate vegetarian protocol built into meal-plan output. Hot-dry summer cold-chain uses gel-pack reconditioning at the Walayar handoff.

Medical Weight Loss in Wayanad

Hill-country plantation workforce with a tapioca staple at glycemic index 85, mandatory alcohol screen before titration, and Thamarassery-ghat cold-chain logistics for the 4 to 8 degree Celsius pen window.
Common Questions

Frequently Asked Questions

The SuperHuman Program is DermaVue's dermatologist-led, dietitian-supported medical weight loss program combining GLP-1 medications (Mounjaro/Tirzepatide or Ozempic/Semaglutide) with dermatologist skin protection, body composition monitoring, and nutrition guidance.

Patients with BMI ≥25 (Indian standard), or BMI 23 to 27 with metabolic risk factors such as prediabetes, high waist circumference, PCOS, or fatty liver. A doctor assessment determines eligibility after lab review.

Mounjaro (Tirzepatide) activates both GIP and GLP-1 receptors (dual mechanism), achieving up to 22.5% weight loss in the SURMOUNT-1 trial. Ozempic (Semaglutide) activates only GLP-1 receptors, achieving up to 14.9% in the STEP 1 trial. DermaVue recommends Mounjaro as first-line for most patients.

Start with a WhatsApp inquiry or book a consultation. Your first step is a 45 to 60 minute dietitian assessment, followed by a mandatory lab panel. Once labs are reviewed, your dermatologist creates a personalized GLP-1 treatment plan. The entire onboarding takes about 1 to 2 weeks.

Ozempic Face refers to facial volume loss that can occur with rapid weight loss on GLP-1 therapy. DermaVue's Face-Saver Protocol uses Profhilo bioremodeling at Month 2, Polynucleotides at Month 3, and MFU-V/Ultherapy from Month 6 to prevent and restore facial volume.

Yes, with appropriate medical screening. Indian consensus guidelines define overweight as BMI ≥23. GLP-1 therapy is particularly effective for the Indian thin-fat phenotype with central obesity and metabolic risk at normal Western BMI cutoffs.

Baseline labs include HbA1c, Fasting Insulin, HOMA-IR calculation, Complete Lipid Panel, TSH, LFT (ALT/AST), Kidney Function (eGFR), Vitamin D3, and B12. The lab form is sent after the dietitian consultation.

Without proper supervision, up to 45% of GLP-1 weight loss can be lean muscle. DermaVue's SuperHuman Program prevents this through protein optimization (1.2 to 1.6 g/kg ideal body weight), resistance training guidance, creatine supplementation, and monthly body composition tracking.

7 Locations Across South India

Visit Any of Our 7 Clinics

Or book a teleconsultation from anywhere in India

Thiruvananthapuram
Kerala
★ 4.7 (1309+)
+91 83308 60007
Kollam
Kerala
★ 4.9 (370+)
+91 80868 60465
Thiruvalla
Kerala
★ 4.8 (3221+)
+91 80860 00608
Kottayam
Kerala
★ 4.8 (558+)
+91 81298 83331
Aluva
Kerala
★ 4.8 (1438+)
+91 90720 07733
Thrissur
Kerala
★ 4.9 (262+)
+91 73567 42225
Coimbatore
Tamil Nadu
★ 4.9 (123+)
+91 80868 60018
Book In-Clinic Consultation WhatsApp for Teleconsultation

Reviewed by Dr. Rejeesh Menon, MD · Last updated 7 April 2026

Start Your Transformation

Ready to Begin?

Book a consultation at any of our 7 clinics, or start with a WhatsApp inquiry from anywhere in India. Your physician-supervised weight loss program starts with one conversation.

WhatsApp Us to Get Started Book In-Clinic Consultation